Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I got it when a friend cooked up crabs
He became very ill and was kind enough to make sure I got it too. What are friends for right? BTW I never touched those crabs. Highly contagious is Norovirus, and no walk in the park either. If not off the throne in two days. I'd seek medical attention or at least qualified medical phone advice just to be on the safe side.
Take care, no fun.
2 year old info take care of yourself
Mytesi (crofelemer) is an FDA-approved medication primarily indicated for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS who are on antiretroviral therapy. Crofelemer works by inhibiting chloride channels in the gastrointestinal tract, thereby reducing fluid secretion and improving diarrhea symptoms.
While Mytesi has been shown to be effective for certain types of diarrhea, it is not indicated for norovirus infection specifically. Norovirus is a highly contagious virus that causes gastroenteritis, characterized by symptoms such as vomiting, diarrhea, nausea, and stomach cramps. Norovirus-related diarrhea is typically self-limiting and resolves on its own within a few days.
There is currently no specific antiviral medication approved for the treatment of norovirus infection. Management usually involves supportive care, such as staying hydrated to prevent dehydration and taking steps to relieve symptoms like nausea and diarrhea. In some cases, healthcare providers may prescribe antiemetics or antidiarrheal medications to manage symptoms, but these do not target the virus itself.
If you suspect you have norovirus or are experiencing symptoms of gastroenteritis, it's essential to stay hydrated and seek medical advice if symptoms are severe or persistent. While Mytesi may be effective for certain types of diarrhea, it's important to consult a healthcare professional for guidance on appropriate treatment for norovirus infection.
What's all this jazz about "AACR" anyway? 🤔
The AACR Annual Meeting is a prominent scientific conference organized by the American Association for Cancer Research (AACR). It is one of the largest gatherings of cancer researchers and professionals worldwide. The conference typically features presentations on cutting-edge cancer research, including basic science, translational research, clinical trials, and emerging therapies.
Held annually in various cities, the AACR Annual Meeting attracts thousands of attendees, including researchers, clinicians, industry professionals, advocates, and policymakers. It provides a platform for the exchange of knowledge, collaboration, and networking among experts in the field of cancer research and treatment.
The conference includes presentations of original research, plenary sessions with renowned speakers, educational workshops, poster sessions, and networking opportunities. It serves as a catalyst for advancing cancer research and translating scientific discoveries into improved patient care.
I'd be a liar saying I wasn't excited STOKED sir.
Just remember that golden rule, never trade on emotion. (dead pan face 😑)
Huh funny you mention asked AI wrong question! 🫢
Nova Pharmaceuticals should be upping there anti to my mind. I'm keeping an eye out for that. 2.7 million is a ship load for sure. If this is going beyond $5 though... I'm hunching they'll buy more at some stage 🫰
Jaguar still committed to local harvester sustainability?
Won't pull up now searched last night & just now
Wasn't a big super busy board by any means but loyal longs who'd been in a while. If I find it again I'll post, best I can do...
Most won't understand significance of international certification status for this drug therapy.
Fly right over there heads, yet management do. I'll be pouring over this intentionally late 8K this weekend for tasty tidbits. In retrospect this after close filing was a great call by management. Being fair to all interested investors means a lot* to would be investors. Kudos Lisa, stay classy!
Just popping over to Frankfurt longs see what they think of all the day's twists and turns They will be a most interesting bell whether come Monday morning. I suspect our institutional brethren will be flexing there muscles Monday as well. Thanks Sonic!
What a trading session just incredible. Haven't eaten all day, just too enthralled with all the momentously powerful developments. Still can't get my head through the door. Might need the Jaws of Life.
Go JAGX! 💰💰
Just wish I had more funds dah monstah!
Congratulations to you! I gotta like your timing here👍
Welcome aboard hunch I know you from somewhere 🤔
For those not into Benzinga, here's a transcript.
Jaguar Health Inc
JAGX
shares are trading higher by 53.7% to $0.09, despite a lack of company-specific news for the session. The company last Friday provided an update on its listing status with the Nasdaq Stock Market. The company requested a hearing to appeal a potential delisting of its securities from Nasdaq, which has been scheduled.
Despite the potential delisting, Jaguar’s common stock will continue to trade on Nasdaq under the symbol ‘JAGX’ pending the outcome of the appeal process. The company was notified by Nasdaq in May 2023 that its stock bid price had closed below the required $1.00 per share for continued listing.
A grace period was granted until May 6, to regain compliance. However, as of February 14, the closing bid price fell to $0.10 or less for 10 consecutive trading days, triggering Nasdaq’s “Low Priced Stocks Rule” and the intention to delist Jaguar’s securities on February 26, unless the company appeals before the Nasdaq Hearings Panel.
There’s no assurance that the company will obtain an extension period to regain compliance.
How To Buy JAGX Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Jaguar Health’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from Benzinga Pro, JAGX has a 52-week high of $1.83 and a 52-week low of $0.05.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
🎙️JAGX, Houston. Ignition sequence in roughly 55 hours🎙️
Make sure you rest up. Our early modelling shows possible turbulence about the $1 area of the flight. Nothing dramatic will keep you posted JAGX. Enjoy your flight Monday. Houston out.
https://www.tradingview.com/news/benzinga:ada294b4c094b:0-what-in-the-world-is-going-on-with-jaguar-health-jagx-stock/
TG looks like end fell off your post?
I hunch I know what it says but for clarity...
Awesome post thank you very kindly sir. JAGX 💰💰
Wow fortune favours the brave, nice going 👌
Shorty's got his package in a knot now
Man the gun rails they didn't cover in after market, they're scurrying to bail out. Now praying for a lull Monday which they very likely won't get. I think the chance of a squeeze Monday just got a whole lot better.
Many more longs are seeing the very real case for a JAGX moonshot as of today. Even if** there's a lull Monday... JAGX is only getting closer and closer to ignition. Sucks to be short on this launch, that's a fact. The weekend radars will be popping for 60 hours straight.
This will get very messy for our ardent negativos. I honestly don't know why they're still here? Even I could see the approaching bullishness, no idea why they couldn't! 🤷
.09 aftermarket so far, here comes Manic Monday
Loop charged bashers and all. Should be entertaining to say the least
Excellent thanks that should be quite the reveal 👍
Most likely JAGX competitor would be my hunch
Makes the most sense to me, we have been on his $h*t list at least several days now. Seems very accomplished, he was hammering 3 or more stocks at a time today. Busy boy! 🫢
Thanks for the link shorts have quadrupled since you posted it several days ago.
https://fintel.io/ss/us/jagx
You are a glutton for punishment sir, seriously?
I was thoroughly enjoying the in depth DD. Delightful change from supposition, and I'm very confident our PHD (double PHD?) lead researcher and vice prez is well aware of AARC with 30 years experience under her belt. First I heard of the conference, Biopharma not my usual focus, how can you tell.
Monday could get especially interesting but I'm still sitting tight for the big bight for sure. Lovely to land a lunker for a change. That sure seems what this is alright, even more so from our AARC poster theory (welcome aboard!) . Thank you to all for the great discussions and awesome insights today, most interesting indeed. Truly a breath of fresh air. My word keep them coming, quite fascinating. GLTYA for Monday and beyond. Couldn't forget Buzz Lightyear now could I? 🙈🙉🙊
What's up Doc? Volume climbed 20% above average in dollar volume. Hmmm 🤔 Gentle Wave about to grow into a Tsunami of progressive dentist's offices, Bristol Meyers Squibb or someone else, NYSE rang up Bjarne for next week's zoom meeting perhaps.
Indulge me, anything's probable with the best tooth treatment on the planet.
Is IHUB slow or in it's death throws 🥱
Call me impatient, flipper whatever cranks your tractor... but seems to me a certain high level zoom meeting should be surfacing on a post near you soon. Did I miss the memo maybe?
Alrrighty no worries I'm in no hurry.
This company obviously has a very good product and have a healthy shot at getting relisted. Excellent odds for JAGX to make it happen so sitting tight, thanks for the reply.
Highly experienced PhD Researcher in Microbiology
Why is she attending this conference exactly. Is it confirmation of Phase 3. Feels like I'm getting my wires crossed somewhere. Perhaps JAGX is attending in search of funding. Can you clarify please...
https://bcic.bio.org/speakers/karen-brunke-phd?&filters.Sessions=__hasValue&searchgroup=libraryentry-speakers
Well there's proof of the Hedge Fund.
Explains perfectly why SONX can't break out of the. 20 cent channelling without significant news. Thanks Scottie
Wow some guy emptied his pockets grabbed 100 shares.
Whew-wee must have a bunch by now, same nibbler every day it seems.
In kind of thick there, aren't you Gov...
Well you want to be miiiighty careful with this firecracker. News could hit at any time... Lest you get trampled into sardines by the marauding stampede that is. Tsk tsk, a tad grizzly scenario Gov. You take care there.
JAGX, relisting/ cancer therapy play phase 3
Any hint of good news and you'll need to invest in a good** pair of binoculars 🫢
Ok thank you Bob, that sounds much better.
I was thinking the CEO was only guy and he was making cold calls kinda thing. Phew, way better, much appreciated 👍
Take a closer look at this filing last year.
This is Bjarne's Venture Capital LLC. Now obviously Olav is a relative of Bjarne's ok fair ball nothing really unusual. But why is Fjordvest investing in there own* company Sonendo. What precipitated that, was it Michael Masters who later filed the Form 13D with 5,000,000 shares of Sonendo. There's more than meets the eye here.
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=317934924&type=HTML&symbol=SONX&cdn=09bacb64544e681400164b69c20f8baa&companyName=Sonendo+Inc.&formType=4&formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&dateFiled=2023-12-19
Gee whiz never knew that.
220 employees is a very sizeable company. Well great to know and likely greater numbers since those filings 10 days ago.
Definitely at least several options for Sonendo
The one I would like to see is a reverse merger. What that does is facilitate a private company going public where the private company acquires Sonendo and they also get a listing on the NYSE in the process. That's probably the best bargaining chip for Sonendo in a Reverse Merger. The agreed to price will take some negotiation and lots of back and forth counter proposals so any reverse merger would not be an instantaneous event or any slam dunk. It would likely start with a LOI or a MOU signifying that the two parties have commenced negotiations. That PR would attract a lot of attention and be more centered on an agreed to buyout figure rather than just MOMO or FOMO in a relisting.
Really, what would make you think that, Link?
Was there a significant event two weeks ago?
Highly possible SONX is a takeover target.
Indeed it might be an AI company that takes a shine to Sonendo, why not! But if that were the case, our friendly CEO could very plausibly be under Non Disclosure restrictions.
Is that the real* reason for the 4 money managers literally out of no where? Sonendo is getting bought out. Well these money managers suddenly all showed up at the same time for legitimate reasons obviously. So again a plausible scenario. No I'll go one further because these money managers all show up on the same day. Now that is highly significant of a major development going down like David Lee Roth wisely points out. For that sudden same day filing pow wow then. I'm going to say chances are PROBABLE* there's a merger, JV or major affiliate getting really chummy with SONX as we speak.
A merger is certain to be less difficult a path in getting on the NYSE than any self powered Sonendo initiative to relist. So I'm going to use that other P-word here.
P-A-T-I-E-N-C-E !!! 🌴
50+ days ago we were expecting relisting PR
That's the news the clear majority want to hear. I put a call into CEO about 4-5 days ago. No contact, radio silence. There's two ways to see this. He's too busy. He's not picking up the phone. From the filings he's probably busier than a one armed basketball player in the NBA finals, I agree. Still though it's pretty darn long to wait for news on something that presented itself as imminent last year. No idea* what's taking this long. Did ChartZilla visit the office and the executive all immediately resigned? Well Trump is still running for president so anything is possible. But ChartZilla is a self confessed homebody so highly HIGHLY inplausible IMHO.
Bristol Meyers Squibb 🤔
20¢ ceiling persisting over a month now.
It's going to take news to break out of this Hedge Fund choke hold. Filings are very interesting but...
You mean cleaning out infected wounds, septic acne?
I've never looked at Gentle Wave from that perspective before, a totally new category interesting.
Once you felt (and expressed) that Sonendo wasn't promoting themselves enough in the media. On reflection there might be something Sonendo can do better. With so much game changer tech in Gentle Wave's line up. It's easy to forget Sonendo is not just an oral health play but also an Artificial intelligence stock as well.
At over 1,000,000 different frequencies firing simultaneously, that's some high tech sterilization going on all for your happy teeth. I don't know maybe it's intellectual property Sonendo might prefer other companies didn't become too familiar with. Being something of a tech nerd I'd be keen to know how more about the AI side of Gentle Wave.
But if Bjarne Bergheim is being intentionally secretive. I think with other companies and nations itching to find a loophole for knockoffs around the patents for there own gain could prove catastrophic. It's still acceptable to me if Sonendo prefers to remain quiet about there AI tech. Then I'm good with the enigmatic media read on Artificial Intelligence. Especially if they are planning another totally different industry for there revenue stream, perhaps laying low is the more prudent strategy.
Good post Scottie 😎
70 cents yet? Got a plane to catch
and my masseuse is booked for an in flight treatment. I'll be hard to catch for a couple of hours so trying to get the latest.
Where are these dilutive 3million odd shares coming from...
Do you mean the (3) 13 G forms and the (1) 13 D form? That's the only thing I can think of you're referring too. Slight problem, the numbers of shares don't jive. So what are you getting at here. I must of missed something...